Serum anticholinergic activity in a community-based sample of older adults

Relationship with cognitive performance

Benoit H. Mulsant, Bruce G. Pollock, Margaret Kirshner, Changyu Shen, Hiroko Dodge, Mary Ganguli

Research output: Contribution to journalArticle

226 Citations (Scopus)

Abstract

Background: Serum anticholinergic activity (SAA), as measured by a radioreceptor assay, quantifies a person's overall anticholinergic burden caused by all drugs and their metabolites. In several small geriatric patient groups, SAA has been associated with cognitive impairment or frank delirium. To our knowledge, there has not yet been any systematic study of the prevalence of SAA and its effect on cognition in a community-based population. Methods: Serum anticholinergic activity was measured in 201 subjects who were randomly selected among the participants in an epidemiological community study, based on their age and sex. Cognitive performance was assessed with use of the Mini-Mental State Examination. The association between SAA and cognitive performance was examined using a univariate analysis and a multiple logistic regression model, adjusting for age, sex, educational level, and number of medications. Results: Serum anticholinergic activity was detectable in 180 (89.6%) participants (range, 0.50-5.70 pmol/mL). Univariate testing showed a significant association between SAA and Mini-Mental State Examination scores. Logistic regression analysis indicated that subjects with SAA at or above the sample's 90th percentile (ie, SAA ≥2.80 pmol/mL) were 13 times (odds ratio, 1.08-152.39) more likely than subjects with undetectable SAA to have a Mini-Mental State Examination score of 24 (the sample's 10th percentile) or below. Conclusions: To our knowledge, this is the largest analysis of SAA and the first to examine its extent and relationship with cognitive performance in a community sample. Its results suggest that SAA can be detected in most older persons in the community and confirm that even low SAA is associated with cognitive impairment.

Original languageEnglish (US)
Pages (from-to)198-203
Number of pages6
JournalArchives of General Psychiatry
Volume60
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Cholinergic Antagonists
Serum
Logistic Models
Radioligand Assay
Delirium
Geriatrics
Cognition
Epidemiologic Studies
Cross-Sectional Studies

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Serum anticholinergic activity in a community-based sample of older adults : Relationship with cognitive performance. / Mulsant, Benoit H.; Pollock, Bruce G.; Kirshner, Margaret; Shen, Changyu; Dodge, Hiroko; Ganguli, Mary.

In: Archives of General Psychiatry, Vol. 60, No. 2, 01.02.2003, p. 198-203.

Research output: Contribution to journalArticle

Mulsant, Benoit H. ; Pollock, Bruce G. ; Kirshner, Margaret ; Shen, Changyu ; Dodge, Hiroko ; Ganguli, Mary. / Serum anticholinergic activity in a community-based sample of older adults : Relationship with cognitive performance. In: Archives of General Psychiatry. 2003 ; Vol. 60, No. 2. pp. 198-203.
@article{4ffb17637f124c2d9dc6fec75bdbb898,
title = "Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance",
abstract = "Background: Serum anticholinergic activity (SAA), as measured by a radioreceptor assay, quantifies a person's overall anticholinergic burden caused by all drugs and their metabolites. In several small geriatric patient groups, SAA has been associated with cognitive impairment or frank delirium. To our knowledge, there has not yet been any systematic study of the prevalence of SAA and its effect on cognition in a community-based population. Methods: Serum anticholinergic activity was measured in 201 subjects who were randomly selected among the participants in an epidemiological community study, based on their age and sex. Cognitive performance was assessed with use of the Mini-Mental State Examination. The association between SAA and cognitive performance was examined using a univariate analysis and a multiple logistic regression model, adjusting for age, sex, educational level, and number of medications. Results: Serum anticholinergic activity was detectable in 180 (89.6{\%}) participants (range, 0.50-5.70 pmol/mL). Univariate testing showed a significant association between SAA and Mini-Mental State Examination scores. Logistic regression analysis indicated that subjects with SAA at or above the sample's 90th percentile (ie, SAA ≥2.80 pmol/mL) were 13 times (odds ratio, 1.08-152.39) more likely than subjects with undetectable SAA to have a Mini-Mental State Examination score of 24 (the sample's 10th percentile) or below. Conclusions: To our knowledge, this is the largest analysis of SAA and the first to examine its extent and relationship with cognitive performance in a community sample. Its results suggest that SAA can be detected in most older persons in the community and confirm that even low SAA is associated with cognitive impairment.",
author = "Mulsant, {Benoit H.} and Pollock, {Bruce G.} and Margaret Kirshner and Changyu Shen and Hiroko Dodge and Mary Ganguli",
year = "2003",
month = "2",
day = "1",
doi = "10.1001/archpsyc.60.2.198",
language = "English (US)",
volume = "60",
pages = "198--203",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Serum anticholinergic activity in a community-based sample of older adults

T2 - Relationship with cognitive performance

AU - Mulsant, Benoit H.

AU - Pollock, Bruce G.

AU - Kirshner, Margaret

AU - Shen, Changyu

AU - Dodge, Hiroko

AU - Ganguli, Mary

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Background: Serum anticholinergic activity (SAA), as measured by a radioreceptor assay, quantifies a person's overall anticholinergic burden caused by all drugs and their metabolites. In several small geriatric patient groups, SAA has been associated with cognitive impairment or frank delirium. To our knowledge, there has not yet been any systematic study of the prevalence of SAA and its effect on cognition in a community-based population. Methods: Serum anticholinergic activity was measured in 201 subjects who were randomly selected among the participants in an epidemiological community study, based on their age and sex. Cognitive performance was assessed with use of the Mini-Mental State Examination. The association between SAA and cognitive performance was examined using a univariate analysis and a multiple logistic regression model, adjusting for age, sex, educational level, and number of medications. Results: Serum anticholinergic activity was detectable in 180 (89.6%) participants (range, 0.50-5.70 pmol/mL). Univariate testing showed a significant association between SAA and Mini-Mental State Examination scores. Logistic regression analysis indicated that subjects with SAA at or above the sample's 90th percentile (ie, SAA ≥2.80 pmol/mL) were 13 times (odds ratio, 1.08-152.39) more likely than subjects with undetectable SAA to have a Mini-Mental State Examination score of 24 (the sample's 10th percentile) or below. Conclusions: To our knowledge, this is the largest analysis of SAA and the first to examine its extent and relationship with cognitive performance in a community sample. Its results suggest that SAA can be detected in most older persons in the community and confirm that even low SAA is associated with cognitive impairment.

AB - Background: Serum anticholinergic activity (SAA), as measured by a radioreceptor assay, quantifies a person's overall anticholinergic burden caused by all drugs and their metabolites. In several small geriatric patient groups, SAA has been associated with cognitive impairment or frank delirium. To our knowledge, there has not yet been any systematic study of the prevalence of SAA and its effect on cognition in a community-based population. Methods: Serum anticholinergic activity was measured in 201 subjects who were randomly selected among the participants in an epidemiological community study, based on their age and sex. Cognitive performance was assessed with use of the Mini-Mental State Examination. The association between SAA and cognitive performance was examined using a univariate analysis and a multiple logistic regression model, adjusting for age, sex, educational level, and number of medications. Results: Serum anticholinergic activity was detectable in 180 (89.6%) participants (range, 0.50-5.70 pmol/mL). Univariate testing showed a significant association between SAA and Mini-Mental State Examination scores. Logistic regression analysis indicated that subjects with SAA at or above the sample's 90th percentile (ie, SAA ≥2.80 pmol/mL) were 13 times (odds ratio, 1.08-152.39) more likely than subjects with undetectable SAA to have a Mini-Mental State Examination score of 24 (the sample's 10th percentile) or below. Conclusions: To our knowledge, this is the largest analysis of SAA and the first to examine its extent and relationship with cognitive performance in a community sample. Its results suggest that SAA can be detected in most older persons in the community and confirm that even low SAA is associated with cognitive impairment.

UR - http://www.scopus.com/inward/record.url?scp=0037315114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037315114&partnerID=8YFLogxK

U2 - 10.1001/archpsyc.60.2.198

DO - 10.1001/archpsyc.60.2.198

M3 - Article

VL - 60

SP - 198

EP - 203

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 2

ER -